| Original language | English (US) |
|---|---|
| Pages (from-to) | 165-168 |
| Number of pages | 4 |
| Journal | Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration |
| Volume | 15 |
| Issue number | 3-4 |
| DOIs | |
| State | Published - Jun 2014 |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 15, No. 3-4, 06.2014, p. 165-168.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Quality improvement in neurology
T2 - Amyotrophic Lateral Sclerosis Quality Measures
AU - Miller, Robert G.
AU - Brooks, Benjamin Rix
AU - Swain-Eng, Rebecca J.
AU - Basner, Robert C.
AU - Carter, Gregory T.
AU - Casey, Patricia
AU - Cohen, Adam B.
AU - Dubinsky, Richard
AU - Forshew, Dallas
AU - Jackson, Carlayne E.
AU - Kasarskis, Ed
AU - Procaccini, Nicholas J.
AU - Sanjak, Mohammed
AU - Tolin, Fredrik P.
N1 - Funding Information: Dr. Miller has received research support from the Muscular Dystrophy, and is a consultant for Cytokinetics, Neuraltus, and Asubio pharmaceuticals. Dr. Brooks has received funding and/or research grants from AB Science, Acorda, ALS Therapy Alliance, Asubio, Avanir., Biogen Idec, Bristol-Myers Squibb, Cytokinetics, GlaxoSmithKline, Knopp Bioscience, Muscular Dystrophy Association, Neu-raltus, NINDS Clinical Research Consortium, QuestCor, and Teva. Ms. Swain-Eng is a full-time employee of the American Academy of Neurology. Dr. Basner is Principal Investigator of a Muscular Dystrophy Association grant,Opto-Electronic Plethysmography (OEP): A novel non-invasive quantitative assessment of lower rib cage paradox and use of accessory muscles in patients with amyotrophic lateral sclerosis; Site Investigator and Sleep Protocol Subcommittee member of an NHLBI/NIH grant, Sleep-Disordered Breathing During Pregnancy and Risks to Cardiovascular Health; and co-investigator of the following: R01HL103676-01A1 NIH/NHLBI; Subclinical Interstitial Lung Disease in MESA; R01HL093081 NIH/NHLBI; Pulmonary Vascular Changes in Early COPD; and InterMune PIPF-016: a randomized, double-blind, placebo-controlled, phase 3 study of the efficacy and safety of Pirfenidone in patients with Idiopathic Pulmonary Fibrosis (IPF). Dr. Carter reports no disclosures. Ms. Casey is a full-time employee of Northwestern Medical Faculty Foundation, Department of Neurology. Dr. Cohen reports no disclosures. Dr. Dubinsky reports disclosures for relationships with Allergan Pharmaceuticals, NIH, and AHRQ. Ms. Forshew is a consultant for Questcor and Asubio Pharmaceuticals. Dr. Jackson has received research support from Knopp Pharmaceuticals, Biogen Idec, and Cytoki-netics. Dr. Kasarskis is a consultant for Asubio Pharmaceuticals and ATSDR. Dr. Procaccini reports no disclosures. Dr. Sanjak reports no disclosures. Dr. Tolin reports no disclosures.
PY - 2014/6
Y1 - 2014/6
UR - https://www.scopus.com/pages/publications/84901501437
UR - https://www.scopus.com/pages/publications/84901501437#tab=citedBy
U2 - 10.3109/21678421.2013.875706
DO - 10.3109/21678421.2013.875706
M3 - Review article
C2 - 24707820
AN - SCOPUS:84901501437
SN - 2167-8421
VL - 15
SP - 165
EP - 168
JO - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
JF - Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
IS - 3-4
ER -